During the recent Global Pharmaceutical Quality Summit 2024, Shanghvi spoke about navigating supply chain challenges, creating a culture of quality in business, and more
An increasing number of platforms are enabling women to connect with one another by breaking the boundaries between the professional and personal
At a recent event, the co-chairman and managing director of Dr Reddy's Laboratories spoke about patient centricity in the health care industry, the enabling power of technology, and how the Indian pharma industry is not celebrated enough
The Forest Essentials founder talks about what it takes to build a credible and iconic luxury Ayurvedic beauty brand from the ground up and its foray into global markets
The leader speaks exclusively with Forbes India about creating three new universes, India as an innovation hub, deploying 'costly' AI for the right use-cases, and possible new sectors that the company can foray into
Gupta entered the data services sector two decades ago. The rest of the world is just about foraying into it. Yotta is now making an audacious bet of spending $1 billion to procure Nvidia's most powerful semiconductor chips. A look into the pioneering entrepreneur and his vision
India has, over the years, established such a firm position for itself that a contrarian election outcome isn't significant enough to derail that, says the senior partner at the consultancy Bain & Company
The executive vice president and global head of banking and financial services at Infosys says that digitalisation using cloud computing and AI is helping banks become more versatile financial services providers
The co-founder of Incedo Inc, a US-based data transformation company, talks about his new book, the digital age, and the synergistic relationship between data and AI
Jar nudges you to make investing in gold a daily affair, by providing the means to invest in it with as little as Rs 10 or Rs 20, to turn your small, ad hoc savings, to systematic daily savings that can be automated
Novo Nordisk, maker of the blockbuster drugs for diabetes and weight loss respectively, has a market capitalisation of $592.02 billion, making it larger than the entire Danish economy. The company's global CEO talks about its India plans and the need for competition to ramp up innovation in pharma